MusclePharm (OTCMKTS:MSLP) Stock Price Passes Below Two Hundred Day Moving Average of $0.23
MusclePharm (OTCMKTS:MSLP) Stock Price Passes Below Two Hundred Day Moving Average of $0.23
MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.23 and traded as low as $0.20. MusclePharm shares last traded at $0.20, with a volume of 110 shares.
在週四的交易中,MusclePharmCo.的股價跌破了200日移動均線,200日移動均線切入位為0.23美元,最低交易價格為0.20美元。MusclePharm股價最新報0.20美元,成交量為110股。
MusclePharm Stock Performance
MusclePharm股票表現
The company has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.23.
該公司的50日簡單移動均線切入位為0.18美元,200日簡單移動均線切入位為0.23美元。
About MusclePharm
關於MusclePharm
(Get Rating)
(獲取評級)
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.
公司在美國和國際上開發、製造、營銷和分銷運動營養品和營養補充劑。該公司提供一系列高性能粉末、膠囊、片劑、凝膠和隨時可用的零食。該公司的MusclePharm品牌產品組合包括戰鬥蛋白粉和戰鬥擠壓蛋白棒;以及支鏈氨基酸、肌酸、谷氨醯胺、肉鹼、共軛亞油酸、魚油、多種維生素和其他產品等基本補充劑。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- 免費獲取StockNews.com關於MusclePharm的研究報告(MSLP)
- MarketBeat:回顧一週9/5-9/9
- 為網絡安全股創紀錄的季度做準備
- 汽車市場正在緩慢復甦,這些股票可能表現優異
- DocuSign是否即將發生重大逆轉?
- 石油和天然氣股票:投資可再生能源的安全途徑
Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.
接受MusclePharm日報的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊收到對MusclePharm和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。